Currently out of the existing stock ratings of Marie Thibault, 225 are a BUY (94.14%), 14 are a HOLD (5.86%).

Marie Thibault

Work Performance Price Targets & Ratings Chart

Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 47.38% that have a potential upside of 37.8% achieved within 169 days.

Marie Thibault’s has documented 459 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on HAE, Haemonetics at 17-Aug-2026.

Wall Street Analyst Marie Thibault

Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.

Average potential price target upside

of $36.65 (15.84%) on PODD (INSULET).
of $30.73 (27.98%) on IRTC (IRHYTHM TECHNOLOGIES).
of $27.54 (26.78%) on ABT (ABBOTT LABORATORIES).

ABT Abbott Laboratories AFIB Acutus Medical ATRC AtriCure BSX Boston Scientific Corp ESTA Establishment Labs Holdings IRT Independence Realty Trust NARI Inari Medical PEAR Pear Therapeutics SENS Senseonics Holdings STIM Neuronetics VAR Varian Medical Systems VRAY ViewRay DXCM DexCom DCTH Delcath Systems PODD Insulet VAPO Vapotherm VERO Venus Concept ARAY Accuray IRTC iRhythm Technologies ICAD icad inc MASI Masimo EMBC Embecta Corp XAIR Beyond Air HAE Haemonetics OM Outset Medical EW Edwards Lifesciences Corp CBLL CeriBell OBIO Orchestra BioMed Holdings VRA Vera Bradley

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Patrick Wood (MORGAN STANLEY)